Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable Stocks to Invest In. On May 22, 2026, the U.S. Food and ...

Gilead Sciences Inc. (NASDAQ:GILD) is one of the cheap NASDAQ stocks to buy right now. On May 21, Gilead Sciences completed ...

Chronic HDV is considered the most severe form of viral hepatitis. ・Bulevirtide 2 mg is also approved for use in the European Economic Area (EEA). ・Gilead Sciences concluded the acquisition of Germany ...

Despite a recent FDA clinical hold on its HIV treatment trials (GS-1720 and GS-4182) due to a decrease in CD4+ T-cells, Gilead Sciences (NASDAQ:GILD) has shown strong performance this year. Its stock ...

Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults ...

Check out the latest Gilead Sciences Inc. (GILD) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

With a net income margin of 31.00% and upside potential of 24.20%, Gilead Sciences, Inc. (NASDAQ:GILD) ranks among the best ...

Gilead's (GILD) recent breakout to new 52-week highs is constructive and reflects improving investor sentiment around its leadership in HIV therapies and expanding oncology pipeline. The recent ...

Regeneron Pharmaceuticals stock increased by 19% over the past month driven by strong third-quarter earnings and robust sales of its flagship drugs, Dupixent (for eczema and other inflammatory ...

This morning a "Potential Dividend Run Alert" went out for Gilead Sciences Inc (NASD: GILD), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the ...